BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

BioReference Laboratories, Inc. (BRLI) Partners With Sysmex Corporation of America


4/17/2009 11:39:26 AM

New hematology infrastructure sets the stage for laboratories' future growth

MUNDELEIN, Ill., April 16 /PRNewswire/ -- Sysmex America, Inc., a leading medical diagnostic instrument manufacturer and information systems developer, today announced its five-year sole source agreement with BioReference Laboratories, Inc. BioReference Laboratories' purchases include three HST-N Hematology Automation Systems comprised of XE-Series Automated Hematology Analyzers, Sysmex SP-1000i Automated Slidemaker/Stainers and Sysmex-distributed DM96 Automated Digital Cell Morphology Systems. Sysmex WAM decision logic software will bring rules-based intelligence to these automation systems by consolidating data from the multiple instruments and performing expert rules-based functions and results management. The HST-N systems are linked to the AutoSorter II by Motoman, Inc. BioReference Laboratories is the third largest full-service independent commercial clinical laboratory in the United States.

"As an existing customer, the reliability of Sysmex's hematology instruments and services is well known to us. As such, BioReference Laboratories wanted to extend its current working relationship with Sysmex to include its Intelligent Automation Solution. This solution will enable us to maximize our testing capacity, minimize human intervention; improve results turnaround time and enhance the overall efficiencies of our laboratory operations," said Warren Erdmann, Senior Vice President and Director of Operations, BioReference Laboratories, Inc. Feedback from BioReference Laboratories' administration, pathologists, laboratory professionals and the company's purchasing department contributed to vendor selection. System implementation and live start-up is scheduled for summer 2009.

"We are pleased that Sysmex's hematology products and services have met BioReference Laboratories' performance standards. We look forward to being a part of their growth as the company continues to lay the groundwork for a sustainable future," said John Kershaw, President, Sysmex America, Inc.

BioReference Laboratories' Sysmex Intelligent Automation Solution enables hands-free hematology testing, slide making and staining, sorting, archiving, repeat testing and decision processes; while achieving the highest throughputs within one of the industry's smallest footprints. BioReference also will benefit from the XE-5000's FDA-cleared body fluid analysis applications.

"By standardizing instrument platforms, information integration, and advanced technologies, laboratories can achieve unparalleled levels of optimization for laboratory operations that literally transform their productivity - all of which offer the enormous benefit of standardized care and consistency," said Kershaw.

About BioReference Laboratories, Inc.

BRLI is the third largest full service laboratory in the United States and the largest independent laboratory in the Northeastern market, primarily a clinical testing lab servicing physician offices with concentrations in the focused markets of esoteric testing, molecular diagnostic, anatomical pathology and correctional health care. BRLI operates as a national oncology laboratory under its GenPath label. Better science, superior technology and better service have enabled GenPath to earn a reputation as one of the premier hematopathology laboratories in the country. GeneDx, a wholly owned subsidiary, is the BRLI genetics laboratory and is typically recognized as the leading laboratory for testing of rare genetic diseases; GeneDx has now become a technology leader with GenomeDx, based on a CGH array platform and its NextGen sequence offerings that are and will be disease specific.

About Sysmex America, Inc.

Sysmex America, Inc., the U.S. headquarters of Sysmex Corporation (Kobe, Japan), is a world leader in clinical laboratory systemization and solutions, including clinical diagnostics, automation and information systems. Serving customers for over 40 years, Sysmex focuses on extending the boundaries of diagnostic science while providing the management information tools that make a real difference in clinical and operational results for people worldwide. For more information about Sysmex, please visit www.sysmex.com/usa.

CONTACT: Tammy Kutz, Manager, Media & Events of Sysmex America, Inc.,
+1-847-996-4531, kutzt@sysmex.com

Web site: http://www.sysmex.com/



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES